Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end‐stage renal disease
- 4 April 2020
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 22 (5), 813-820
- https://doi.org/10.1002/ejhf.1819
Abstract
Aims To evaluate the risk of heart failure (HF) in patients with type 2 diabetes (T2D) complicated by development of intercurrent ischaemic heart disease (IHD), end‐stage renal disease (ESRD), or both, compared to patients with T2D and no IHD and ESRD. Methods and results From Danish nationwide registries, we identified all patients with new‐onset T2D with no history of HF between 1998 and 2015. Landmark analyses were used to estimate the 5‐year absolute risk of HF at several follow‐up times, and accounted for the occurrence of IHD and ESRD, identified before HF. The Aalen–Johansen estimator was used to account for censoring and the competing risk of death. A total of 285 024 patients with new‐onset T2D were included. During follow‐up, 19 960 developed incident HF. Among patients with T2D free of HF 5 years after T2D diagnosis, patients without IHD and ESRD had the lowest 5‐year risk of HF [4.02%; 95% confidence interval (CI) 3.90–4.15), those with T2D complicated by IHD [11.51%; relative risk (RR) 2.86; 95% CI 2.72–3.02; P < 0.001] or ESRD (8.11%; RR 2.02; 95% CI 1.39–2.93; P < 0.001) an intermediate risk, and those with both IHD and ESRD (19.76%; RR 4.92; 95% CI 3.43–7.05; P < 0.001) the highest risk. Conclusion Patients with T2D complicated by development of intercurrent IHD, ESRD, or both, showed a significantly higher risk of HF compared to those who did not develop IHD and ESRD. An effective way to delay or prevent the development of HF in patients with T2D may be to prevent IHD and ESRD.This publication has 27 references indexed in Scilit:
- Landmark Analysis at the 25-Year Landmark PointCirculation: Cardiovascular Quality and Outcomes, 2011
- The Cardiorenal Syndrome: A ReviewInternational Journal of Nephrology, 2011
- Cardiorenal SyndromeCirculation, 2010
- Risk Factors for Heart Failure: A Population-Based Case-Control StudyThe American Journal of Medicine, 2009
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programmeEuropean Heart Journal, 2008
- Diabetes in Heart Failure: Prevalence and Impact on Outcome in the PopulationThe American Journal of Medicine, 2006
- A systematic review on communicating with patients about evidenceJournal of Evaluation in Clinical Practice, 2005
- Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With NephropathyCirculation, 2004
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974